Mechanisms and treatment of the "afternoon phenomenon" in patients with type 1 diabetes mellitus using glargine as basal insulin

被引：0
|
作者：
Rossetti, P
Porcellati, F
Fanelli, CG
Bolli, GB
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A68 / A68
页数：1
相关论文
共 50 条
  • [21] Intensified insulin therapy of type 2 diabetes mellitus: Insulin glargine vs. insulin detemir as basal insulin
    Jungmann, Eckart
    DIABETES, 2006, 55 : A118 - A118
  • [22] COMPARISON OF COSTS OF THE INSULIN TREATMENT OF TYPE 2 DIABETES MELLITUS WITH INSULIN GLARGINE AND INSULIN DETEMIR
    Guisasola, Alvarez F.
    Puente, Mauricio D.
    Coscolin, Garcia T.
    Terres, Rubio C.
    VALUE IN HEALTH, 2010, 13 (07) : A287 - A287
  • [23] Pregnant women with type 1 diabetes mellitus treated by glargine insulin
    Al-Shaikh, AA
    SAUDI MEDICAL JOURNAL, 2006, 27 (04) : 563 - 565
  • [24] Effect of Exercise on Pharmacokinetics (PK) of Basal Insulin Peglispro (BIL) and Insulin Glargine (GL) in Type 1 Diabetes Mellitus (T1DM) Patients
    Linnebjerg, Helle
    Lam, Eric Chen Quin
    Choi, Siak Leng
    Knadler, Mary P.
    Porksen, Niels
    Sinha, Vikram P.
    Garhyan, Parag
    Klein, Oliver
    Nosek, Leszek
    Heise, Tim
    DIABETES, 2015, 64 : A253 - A253
  • [25] Efficacy of combining insulin glulisine with basal insulin glargine in patients with Type 1 diabetes in everyday clinical practice
    Fiesselmann, A.
    Landgraf, W.
    Schreiber, S.
    DIABETIC MEDICINE, 2008, 25
  • [26] DIABETES DURATION AND THE EFFICACY AND SAFETY OF INSULIN GLARGINE VERSUS COMPARATOR TREATMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Garg, Satish K.
    Aurand, Lisa A.
    Rimler, Michael S.
    Dailey, George E.
    ENDOCRINE PRACTICE, 2014, 20 (02) : 120 - 128
  • [27] Basal Insulin peglispro (BIL) demonstrates hepato-preferential action vs insulin Glargine (GL) in patients with type 1 diabetes mellitus Abstracts
    Mudaliar, S.
    Henry, R. R.
    Ciaraldi, T. P.
    Armstrong, D. A.
    Burke, P. M.
    Pettus, J. H.
    Garhyan, P.
    Choi, S. L.
    Jacober, S. J.
    Knadler, M. P.
    Lam, E. C. Q.
    Prince, M. J.
    Bose, N.
    Porksen, N. K.
    Linnebjerg, H.
    DIABETOLOGIA, 2015, 58 : S1 - S1
  • [28] Reduced intra-subject variability of Basal Insulin peglispro (BIL) compared to insulin Glargine (GL) in patients with type 1 diabetes mellitus Abstracts
    Lam, E.
    Garhyan, P.
    Linnebjerg, H.
    Choi, S.
    Knadler, M. P.
    Sinha, V. P.
    Sassenfeld, B. M.
    Nosek, L.
    Heise, T.
    DIABETOLOGIA, 2015, 58 : S1 - S2
  • [29] A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
    Riccardo Candido
    Kathleen Wyne
    Ester Romoli
    Diabetes Therapy, 2018, 9 : 927 - 949
  • [30] A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus
    Candido, Riccardo
    Wyne, Kathleen
    Romoli, Ester
    DIABETES THERAPY, 2018, 9 (03) : 927 - 949
12345